TCR-like antibodies in cancer immunotherapy
Abstract Cancer immunotherapy has been regarded as the most significant scientific breakthrough of 2013, and antibody therapy is at the core of this breakthrough. Despite significant success achieved in recent years, it is still difficult to target intracellular antigens of tumor cells with traditio...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2019-09-01
|
| Edice: | Journal of Hematology & Oncology |
| Témata: | |
| On-line přístup: | http://link.springer.com/article/10.1186/s13045-019-0788-4 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|